1. National Institute for Health and Clinical
Excellence. Type 2 diabetes: the management
of type 2 diabetes (update). 2008. URL: http://
guidance.nice.org.uk/CG66
2. British Medical Association and the Royal
Pharmaceutical Society of Great Britain. British
National Formulary 57. URL: www.bnf.org/bnf/bnf/
current/104945.htm 2009 (accessed 21 July 2009).
3. McAndrew L, Schneider SH, Burns E, Leventhal
H. Does patient blood glucose monitoring improve
diabetes control? A systematic review of the
literature. Diabetes Educ 2007;33:991–1011.
4. Yorkshire and Humber Public Health Observatory.
URL: www.yhpho.org.uk/ (accessed August 2009).
5. The Health and Social Care Information Centre
PSUatYaHPHO. Prescribing for diabetes in England. An
analysis of volume, expenditure and trends. URL: www.
yhpho.org.uk/resource/item.aspx?RID=9711 2009
(accessed 21 July 2009).
6. Chapman RH, Benner JS, Petrilla AA, Tierce
JC, Collins SR, Battleman DS, et al. Predictors of
adherence with antihypertensive and lipid-lowering
therapy. Arch Intern Med 2005;165:1147–52.
7. Lawton J, Peel E, Douglas M, Parry O. ‘Urine
testing is a waste of time’: newly diagnosed Type 2
diabetes patients’ perceptions of self-monitoring.
Diabet Med 2004;21:1045–8.
8. Lawton J. Patients’ perceptions and experiences of
taking oral glucose-lowering agents: a longitudinal
qualitative study. Diabet Med 2008;25:491–5.
9. Song M, Lipman TH. Concept analysis: selfmonitoring
in type 2 diabetes mellitus. Int J Nurs
Stud 2008;45:1700–10.
10. Farmer A, Wade A, Goyder E, Yudkin P, French
D, Craven A, et al. Impact of self monitoring of
blood glucose in the management of patients with
non-insulin treated diabetes: open parallel group
randomised trial. BMJ 2007;335:132.
11. Farmer AJ, Wade AN, French DP, Simon J, Yudkin P,
Gray A, et al. Blood glucose self-monitoring in type
2 diabetes: a randomised controlled trial. Health
Technology Assessment 2009;13(15).
12. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer
A, et al. Cost-effectiveness of self monitoring of
blood glucose in patients with non-insulin treated
type 2 diabetes: economic evaluation of data from
the DiGEM trial. BMJ 2008;336:1177–80.
13. O’Kane MJ, Bunting B, Copeland M, Coates VE,
ESMON study group. Efficacy of self monitoring of
blood glucose in patients with newly diagnosed type
2 diabetes (ESMON study): randomised controlled
trial. BMJ 2008;336:1174–7.
14. Karter AJ, Parker MM, Moffet HH, Spence MM,
Chan J, Ettner SL, et al. Longitudinal study of
new and prevalent use of self-monitoring of blood
glucose. Diabetes Care 2006;29:1757–63.
15. Martin S, Schneider B, Heinemann L, Lodwig V,
Kurth HJ, Kolb H, et al. Self-monitoring of blood
glucose in type 2 diabetes and long-term outcome:
an epidemiological cohort study. Diabetologia
2006;49:271–8.
16. Wen L, Parchman ML, Linn WD, Lee S. Association
between self-monitoring of blood glucose and
glycemic control in patients with type 2 diabetes
mellitus. Am J Health Syst Pharm 2004;61:2401–5.
17. Davis TME, Van-Minnen K, Bruce DG, Davis WA.
The relationship between self-monitoring of blood
glucose results and glycosylated haemoglobin in
type 2 diabetes: The Fremantle Diabetes Study.
Diabetologia 2007;50:1003.
18. Davis WA, Bruce DG, Davis TM. Is self-monitoring
of blood glucose appropriate for all type 2 diabetic
patients? The Fremantle Diabetes Study. Diabetes
Care 2006;29:1764–70.
19. Davis WA, Bruce DG, Davis TM. Does selfmonitoring
of blood glucose improve outcome in
type 2 diabetes? The Fremantle Diabetes Study.
Diabetologia 2007;50:510–5.
20. Moreland EC, Volkening LK, Lawlor MT, Chalmers
KA, Anderson BJ, Laffel LM. Use of a blood
glucose monitoring manual to enhance monitoring
adherence in adults with diabetes: a randomized
controlled trial. Arch Intern Med 2006;166:689–95.
21. Siebolds M, Gaedeke O, Schwedes U, SMBG
Study Group. Self-monitoring of blood glucose--
psychological aspects relevant to changes in HbA1c
in type 2 diabetic patients treated with diet or diet
plus oral antidiabetic medication. Patient Educ Couns
2006;62:104–10.
22. Palmer AJ, Dinneen S, Gavin JR, III, Gray A,
Herman WH, Karter AJ. Cost-utility analysis in a
UK setting of self-monitoring of blood glucose in
patients with type 2 diabetes. Curr Med Res Opin
2006;22:861–72.
23. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie
D, Stroup DF. Improving the quality of reports
of meta-analyses of randomised controlled trials:
the QUOROM statement. Quality of Reporting of
Meta-analyses. Lancet 1999;354:1896–900.
24. Coster S, Gulliford MC, Seed PT, Powrie JK,
Swaminathan R. Monitoring blood glucose control
in diabetes mellitus: a systematic review. Health
Technol Assess 2000;4(12).
25. Brunner GA, Ellmerer M, Sendlhofer G, Wutte A,
Trajanoski Z, Schaupp L, et al. Validation of home
blood glucose meters with respect to clinical and
analytical approaches. Diabetes Care 1998;21:585–90.
26. Williams CD, Scobie IN, Till S, Crane R, Lowy C,
Sonksen PH. Use of memory meters to measure
reliability of self blood glucose monitoring. Diabet
Med 1988;5:459–62.
27. Arabadjief D, Nichols JH. Assessing glucose meter
accuracy. Curr Med Res Opin 2006;22:2167–74.
28. AHRQ. Applicability of the evidence regarding intensive
glycemic control and self-monitored blood glucose to
Medicare patients with type 2 diabetes. Rockvill, MD:
AHRQ; 2007.
29. Coster S, Gulliford MC, Seed PT, Powrie JK,
Swaminathan R. Self-monitoring in type 2 diabetes
mellitus: a meta-analysis. Diabet Med 2000;17:
755–61.
30. Faas A, Schellevis FG, Van Eijk JT. The efficacy
of self-monitoring of blood glucose in NIDDM
subjects. A criteria-based literature review. Diabetes
Care 1997;20:1482–6.
31. Jansen JP. Self-monitoring of glucose in type 2
diabetes mellitus: a Bayesian meta-analysis of
direct and indirect comparisons. Curr Med Res Opin
2006;22:671–81.
32. McGeoch G, Derry S, Moore RA. Self-monitoring
of blood glucose in type-2 diabetes: what is the
evidence? Diabetes Metab Res Rev 2007;23:423–40.
33. Poolsup N, Suksomboon N, Jiamsathit W. Systematic
review of the benefits of self-monitoring of blood
glucose on glycemic control in type 2 diabetes
patients. Diabetes Technol Ther 2008;10(Suppl. 1):
S51–66.
34. Sarol JN, Nicodemus NA, Jr, Tan KM, Grava MB.
Self-monitoring of blood glucose as part of a multicomponent
therapy among non-insulin requiring
type 2 diabetes patients: a meta-analysis (1966–
2004). Curr Med Res Opin 2005;21:173–84.
35. Towfigh A, Romanova M, Weinreb JE, Munjas B,
Suttorp MJ, Zhou A, et al. Self-monitoring of blood
glucose levels in patients with type 2 diabetes
mellitus not taking insulin: a meta-analysis. Am J
Manag Care 2008;14:468–75.
36. Welschen LM, Bloemendal E, Nijpels G, Dekker
JM, Heine RJ, Stalman WA, et al. Self-monitoring of
blood glucose in patients with type 2 diabetes who
are not using insulin: a systematic review. Diabetes
Care 2005;28:1510–7.
37. Welschen LM, Bloemendal E, Nijpels G, Dekker
JM, Heine RJ, Stalman WA, et al. Self-monitoring
of blood glucose in patients with type 2 diabetes
who are not using insulin. Cochrane Database Syst Rev
2005;CD005060.
38. St John A, Davis WA, Price CP, Davis TM. The value
of self-monitoring of blood glucose: a review of
recent evidence. J Diabetes Complications 2009; in
press.
39. Sarol JN, Nicodemus NA, Tan KM, Flores JVPG.
Self-monitoring of blood glucose as part of a
multi-component treatment strategy in noninsulin
requiring type 2 diabetes mellitus. Diabetes
2004;53:A73.
40. Allen BT, DeLong ER, Feussner JR. Impact of
glucose self-monitoring on non-insulin-treated
patients with type II diabetes mellitus. Randomized
controlled trial comparing blood and urine testing.
Diabetes Care 1990;13:1044–50.
41. Barnett AH, Krentz AJ, Strojek K, Sieradzki J,
Azizi F, Embong M, et al. The efficacy of selfmonitoring
of blood glucose in the management
of patients with type 2 diabetes treated with a
gliclazide modified release-based regimen. A
multicentre, randomized, parallel-group, 6-month
evaluation (DINAMIC 1 study). Diabetes Obes Metab
2008;10:1239–47.
42. Bonomo K, De Salve A, Pignatelli S, Fiora E,
Mularoni E, Cavalot F, et al. Self-monitoring of
blood glucose in type 2 diabetic patients not on
insulin treatment: waist of money or tool to reach
the glyeaemic targets? Diabetologia 2006;49:0815.
43. Brown SA, Garcia AA, Kouzekanani K, Hanis CL.
Culturally competent diabetes self-management
education for Mexican Americans: the Starr County
border health initiative. Diabetes Care 2002;25:
259–68.
44. Cho JH, Chang SA, Kwon HS, Choi YH, Ko SH,
Moon SD, et al. Long-term effect of the Internetbased
glucose monitoring system on HbA1c
reduction and glucose stability: a 30-month followup
study for diabetes management with a ubiquitous
medical care system. Diabetes Care 2006;29:2625–31.
45. Davidson MB, Castellanos M, Kain D, Duran P.
The effect of self monitoring of blood glucose
concentrations on glycated hemoglobin levels in
diabetic patients not taking insulin: a blinded,
randomized trial. Am J Med 2005;118:422–5.
46. Estey AL, Tan MH, Mann K. Follow-up intervention:
its effect on compliance behavior to a diabetes
regimen. Diabetes Educ 1990;16:291–5.
47. Fontbonne A, Billault B, Acosta M, Percheron C,
Varenne P, Besse A, et al. Is glucose self-monitoring
beneficial in non-insulin-treated diabetic patients?
Results of a randomized comparative trial. Diabete
Metab 1989;15:255–60.
48. Gallichan MJ. Self-monitoring by patients
receiving oral hypoglycemic agents: a survey and a
comparative trial. Pract Diabetes 1994;11:28–30.
49. Guerci B, Drouin P, Grange V, Bougneres P,
Fontaine P, Kerlan V, et al. Self-monitoring of blood
glucose significantly improves metabolic control
in patients with type 2 diabetes mellitus: the Auto-
Surveillance Intervention Active (ASIA) study.
Diabetes Metab 2003;29:587–94.
50. Jaber LA, Halapy H, Fernet M, Tummalapalli S,
Diwakaran H. Evaluation of a pharmaceutical care
model on diabetes management. Ann Pharmacother
1996;30:238–43.
51. Johnson JA, Majumdar SR, Bowker SL, Toth EL,
Edwards A. Self-monitoring in Type 2 diabetes: a
randomized trial of reimbursement policy. Diabet
Med 2006;23:1247–51.
52. Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi
SR, Rossi JS, et al. Changes in diabetes self-care
behaviors make a difference in glycemic control:
the Diabetes Stages of Change (DiSC) study. Diabetes
Care 2003;26:732–7.
53. Joy S, Rodgers P, Elmore L, Calvert S. Assessment
of therapeutic interventions and degree of glycemic
control for patients with type 2 diabetes mellitus
using preprandial versus postprandial self blood
glucose monitoring in a primary care setting.
Diabetes 2003;52:A96–7.
54. Kibriya MG, Ali L, Banik NG, Khan AK. Home
monitoring of blood glucose (HMBG) in Type-2
diabetes mellitus in a developing country. Diabetes
Res Clin Pract 1999;46:253–7.
55. Kwon HS, Cho JH, Kim HS, Song BR, Ko SH,
Lee JM, et al. Establishment of blood glucose
monitoring system using the internet. Diabetes Care
2004;27:478–83.
56. Miles P, Everett J, Murphy J, Kerr D. Comparison
of blood or urine testing by patients with newly
diagnosed non-insulin dependent diabetes: patient
survey after randomised crossover trial. BMJ
1997;315:348–9.
57. Muchmore DB, Springer J, Miller M. Selfmonitoring
of blood glucose in overweight type 2
diabetic patients. Acta Diabetol 1994;31:215–19.
58. Rutten G, van EJ, de NE, Beek M, van der Helden
H. Feasibility and effects of a diabetes type II
protocol with blood glucose self-monitoring in
general practice. Fam Pract 1990;7:273–8.
59. Scherbaum WA, Ohmann C, Abholz HH, Lankisch
M. Evaluating the optimal frequency of selfmonitoring
blood glucose in type 2 diabetes at
glycaemic target: a multi-centre, randomized
controlled trial. Diabetes 2007;56:A24.
60. Scherbaum WA, Ohmann C, Abholz HH, Dragano
N, Lankisch M. Effect of the frequency of selfmonitoring
blood glucose in patients with type
2 diabetes treated with oral antidiabetic drugs-a
multi-centre, randomized controlled trial. PLoS
ONE 2008;3:e3087.
61. Schwedes U, Siebolds M, Mertes G. Meal-related
structured self-monitoring of blood glucose: effect
on diabetes control in non-insulin-treated type 2
diabetic patients. Diabetes Care 2002;25:1928–32.
62. Seaton TL. Benefit of self-monitoring of blood
glucose in patients with NIDDM receiving
oral sulfonylureas [abstract]. Pharmacotherapy
1996;16:498.
63. Wing RR, Epstein LH, Nowalk MP, Scott N, Koeske
R, Hagg S. Does self-monitoring of blood glucose
levels improve dietary compliance for obese patients
with type II diabetes? Am J Med 1986;81:830–6.
64. Bajkowska-Fiedziukiewicz A, Cypryk K, Kozdraj T,
Mikolajczyk-Swatko A, Kosinski M, Jozefowska M.
Self-monitoring of blood glucose and treatment
outcomes in type 2 diabetic patients. Polskie
Archiwum Medycyny Wewnetrznej 2008;118:267–72.
65. Banister NA, Jastrow ST, Hodges V, Loop R,
Gillham MB. Diabetes self-management training
program in a community clinic improves
patient outcomes at modest cost. J Am Diet Assoc
2004;104:807–10.
66. Blonde L, Ginsberg BH, Horn S. Frequency of
blood glucose monitoring in relation to glycemic
control in patients with type 2 diabetes. Diabetes Care
2002;25:245–55.
67. Capelson R, Principe A, Trey G, Hayes M, Suhl E,
Ayres D, et al. Does increased home monitoring of
blood glucose (HMBG) improve glycemic control in
patients over 75? Diabetes 2006;55:A453.
68. Chan WB, Chan JC, Chow CC, Yeung VT, So WY,
Li JK, et al. Glycaemic control in type 2 diabetes:
the impact of body weight, beta-cell function and
patient education. QJM 2000;93:183–90.
69. Evans JM, Newton RW, Ruta DA, MacDonald TM,
Stevenson RJ, Morris AD. Frequency of blood
glucose monitoring in relation to glycaemic control:
observational study with diabetes database. BMJ
1999;319:83–6.
70. Franciosi M, Pellegrini F, De Berardis G, Belfiglio
M, Cavaliere D, Di Nardo B, et al. The impact of
blood glucose self-monitoring on metabolic control
and quality of life in type 2 diabetic patients: an
urgent need for better educational strategies.
Diabetes Care 2001;24:1870–7.
71. Franciosi M, Pellegrini F, De Berardis G, Belfiglio
M, Di Nardo B, Greenfield S, et al. Self-monitoring
of blood glucose in non-insulin-treated diabetic
patients: a longitudinal evaluation of its impact on
metabolic control. Diabet Med 2005;22:900–6.
72. Hanninen J, Takala J, Keinanen-Kiukaanniemi
S. Good continuity of care may improve quality
of life in Type 2 diabetes. Diabetes Res Clin Pract
2001;51:21–7.
73. Harris MI, National Health and Nutrition
Examination Survey (NHANES III). Frequency of
blood glucose monitoring in relation to glycemic
control in patients with type 2 diabetes. Diabetes Care
2001;24:979–82.
74. Jaworska J, Dziemidok P, Kulik TB, Rudnicka-
Drozak E. Frequency of self-monitoring and its
effect on metabolic control in patients with type
2 diabetes. Ann Univ Mariae Curie Sklodowska Med
2004;59:310–16.
75. Karter AJ, Ackerson LM, Darbinian JA, D’Agostino
RB, Jr, Ferrara A, Liu J, et al. Self-monitoring of
blood glucose levels and glycemic control: the
Northern California Kaiser Permanente Diabetes
registry. Am J Med 2001;111:1–9.
76. Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed
AT, Ferrara A, et al. Achieving good glycemic
control: initiation of new antihyperglycemic
therapies in patients with type 2 diabetes from the
Kaiser Permanente Northern California Diabetes
Registry. Am J Manag Care 2005;11:262–70.
77. Klein CE, Oboler SK, Prochazka A, Oboler S, Frank
M, Glugla M, et al. Home blood glucose monitoring:
effectiveness in a general population of patients
who have non-insulin-dependent diabetes mellitus.
J Gen Intern Med 1993;8:597–601.
78. Martin S, Kolb H, Schneider B, Heinemann L,
Weber C, Kocher S, et al. Myocardial infarction
and stroke in early years after diagnosis of type 2
diabetes: risk factors and relation to self-monitoring
of blood glucose. Diabetes Technol Ther 2009;11:
234–41.
79. Meier JL, Swislocki AL, Lopez JR, Noth RH,
Bartlebaugh P, Siegel D. Reduction in selfmonitoring
of blood glucose in persons with type
2 diabetes results in cost savings and no change in
glycemic control. Am J Manag Care 2002;8:557–65.
80. Mitchell CG, Bowker SL, Majumdar SR, Toth EL,
Johnson JA. Lack of correlation between patientreported
outcomes and glycemic control in type
2 diabetes not managed by insulin. Can J Diabetes
2004;28:362–8.
81. Murata GH, Shah JH, Hoffman RM, Wendel CS,
Adam KD, Solvas PA, et al. Intensified blood glucose
monitoring improves glycemic control in stable,
insulin-treated veterans with type 2 diabetes: the
Diabetes Outcomes in Veterans Study (DOVES).
Diabetes Care 2003;26:1759–63.
82. Murata GH, Duckworth WC, Shah JH, Wendel
CS, Mohler MJ, Hoffman RM. Blood glucose
monitoring is associated with better glycemic
control in type 2 diabetes: a database study. J Gen
Int Med 2009;24:48–52.
83. Newman WP, Laqua D, Engelbrecht D. Impact
of glucose self-monitoring on glycohemoglobin
values in a veteran population. Arch Intern Med
1990;150:107–10.
84. Oki JC, Flora DL, Isley WL. Frequency and impact
of SMBG on glycemic control in patients with
NIDDM in an urban teaching hospital clinic.
Diabetes Educ 1997;23:419–24.
85. Ozmen B, Boyvada S. The relationship between
self-monitoring of blood glucose control and
glycosylated haemoglobin in patients with type 2
diabetes with and without diabetic retinopathy.
J Diabetes Complications 2003;17:128–34.
86. Patrick AW, Gill GV, MacFarlane IA, Cullen A, Power
E, Wallymahmed M. Home glucose monitoring in
type 2 diabetes: is it a waste of time? Diabet Med
1994;11:62–5.
87. Rindone JP, Austin M, Luchesi J. Effect of home
blood glucose monitoring on the management
of patients with non-insulin dependent diabetes
mellitus in the primary care setting. American J
Manag Care 1997;3:1335–8.
88. Roblin DW, Barizlay JI. Self-monitoring of blood
glucose: Variation in frequency of monitoring
and its association with glycemic control. Diabetes
2001;50:A2.
89. Rost KM, Flavin KS, Schmidt LE, McGill JB. Selfcare
predictors of metabolic control in NIDDM
patients. Diabetes Care 1990;13:1111–3.
90. Schiel R, Muller UA, Rauchfub J, Sprott H, Muller
R. Blood-glucose self-monitoring in insulin treated
type 2 diabetes mellitus a cross-sectional study with
an intervention group. Diabetes Metab 1999;25:
334–40.
91. Schütt M, Kern W, Krause U, Busch P, Dapp A,
Grziwotz R, et al. Is the frequency of self-monitoring
of blood glucose related to long-term metabolic
control? Multicenter analysis including 24,500
patients from 191 centers in Germany and Austria.
Exp Clin Endocrinol Diabetes 2006;114:384–8.
92. Secnik K, Yurgin N, Lage MJ, Donald-Everett C.
Patterns of blood glucose monitoring in relation
to glycemic control among patients with type
2 diabetes in the UK. J Diabetes Complications
2007;21:181–6.
93. Soumerai SB, Mah C, Zhang F, Adams A, Barton
M, Fajtova V, et al. Effects of health maintenance
organization coverage of self-monitoring devices on
diabetes self-care and glycemic control. Arch Intern
Med 2004;164:645–52.
94. Stiptzarov N, Zhang Q, Pogach L. Increased
utilization of self monitoring of blood glucose
(SMBG) is associated with decreased A1c levels.
Diabetes 2003;52:A270.
95. Tengblad A, Grodzinsky E, Lindstrom K, Molstad S,
Borgquist L, Ostgren CJ. Self-monitoring of blood
glucose and glycaemic control in type 2 diabetes.
Scand J Prim Health Care 2007;25:140–6.
96. Wieland LD, Vigil JM, Hoffman RM, Janis LW.
Relationship between home glucose testing and
hemoglobin Alc in type II diabetes patients. Am J
Health Syst Pharm 1997;54:1062–5.
97. Worth R, Home PD, Johnston DG, Anderson J,
Ashworth L, Burrin JM, et al. Intensive attention
improves glycaemic control in insulin-dependent
diabetes without further advantage from home
blood glucose monitoring: results of a controlled
trial. Br Med J (Clin Res Ed) 1982;285:1233–40.
98. International Diabetes Federation. IDF Guideline
on self-monitoring of blood glucose in non-insulin
treated type 2 diabetes. October 2008. URL: www.
idf.org/idf-guideline-self-monitoring-blood-glucosenon-
insulin-treated-type-2-diabetes (accessed 5
December 2009).
99. Schneider B, Martin S, Heinemann L, Lodwig V,
Kolb H. Interrelations between diabetes therapy,
self-monitoring of blood glucose, blood glucose and
non-fatal or fatal endpoints in patients with type
2 diabetes/results of a longitudinal cohort study
(ROSSO 5). Arzneimittelforschung 2007;57:762–9.
100. Belsey JD, Pittard JB, Rao S, Urdahl H, Jameson
K, Dixon T. Self blood glucose monitoring in type
2 diabetes. A financial impact analysis based on UK
primary care. Int J Clin Pract 2009;63:439–48.
101. Peel E, Parry O, Douglas M, Lawton J. Blood
glucose self-monitoring in non-insulin-treated
type 2 diabetes: a qualitative study of patients’
perspectives. Br J Gen Pract 2004;54:183–8.
102. Peel E, Douglas M, Lawton J. Self monitoring of
blood glucose in type 2 diabetes: longitudinal
qualitative study of patients’ perspectives. BMJ
2007;335:493.
103. Zgibor JC, Simmons DS. Barriers to self glucose
monitoring in a multi-ethnic community. Diabetes
2001;50:A500–1.
104. Stewart D, McCaig D, Davie A, Juroszek L,
Blackwood L, Findlay N, et al. Glucose selfmonitoring
in primary care: a survey of current
practice. J Clin Pharm Ther 2004;29:273–7.
105. National Prescribing Centre. When and how should
patients with diabetes mellitus test blood glucose? URL:
www.npc.co.uk/ebt/merec/cardio/diabetes1/resources/
merec_bulletin_vol13_no1.pdf 2002 (accessed 21
July 2009).
106. O’Kane MJ, Pickup J. Self-monitoring of blood
glucose in diabetes: is it worth it? Ann Clin Biochem
2009;46:273–82.
107. Funnell M, Anderson RM. Empowerment and selfmanagement
of diabetes. Clin Diabetes 2004;22:123.
108. Curtis L, Netten A. Unit costs of health and social care
2006. Personal Social Services Research Unit 2006.
URL: www.pssru.ac.uk/pdf/uc/uc2006/uc2006.pdf
(accessed August 2009).
109. Weber C, Schneider B, Lodwig V, Holm MV, Neeser
K. Cost impact of blood glucose self-monitoring
on complications of type 2 diabetes: a Swiss
perspective (ROSSO study No.11). Swiss Med Wkly
2007;137:545–50.
110. Tiley S. Home blood glucose monitoring – What
cost? Pract Diabetes Int 2002;19:S1–4.
111. Neeser K, Weber C, Wenzel H, Schneider B. Costs
of self-measurement of blood glucose (SMBG)
regarding morbidity and mortality in type 2
diabetes in a reality of care setting (The ROSSO
study No. 6). Diabetologia 2006;49:0225.
112. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P,
Stevens RJ, et al. A model to estimate the lifetime
health outcomes of patients with type 2 diabetes:
the United Kingdom Prospective Diabetes Study
(UKPDS) Outcomes Model (UKPDS no. 68).
Diabetologia 2004;47:1747–59.
113. Department of Health. NHS reference costs 2005–06.
URL: www.dh.gov.uk/en/Publicationsandstatistics/
Publications/PublicationsPolicyAndGuidance/
DH_062884 (accessed August 2009).
114. National Health Service. Annual financial returns
of NHS trusts 2003–2004. Leeds: NHS Executive;
2005.
115. Netten A, Curtis L. Unit costs of health and social care
2002. URL: www.pssru.ac.uk/UC2002.htm (accessed
August 2009).
116. Tunis SL, Minshall ME. Self-monitoring of blood
glucose in type 2 diabetes: cost-effectiveness in the
united states. Am Journal Manag Care 2008;14:
131–40.
117. Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos
V, Lurati FM, et al. The CORE Diabetes Model:
projecting long-term clinical outcomes, costs and
cost-effectiveness of interventions in diabetes
mellitus (types 1 and 2) to support clinical and
reimbursement decision-making. Curr Med Res Opin
2004;20:5–26.
118. Aspinall SL, Glassman PA. Cost-effectiveness of
blood glucose monitoring is controversial. Am J
Manag Care 2008;14:398–9.
119. Tunis SL. Cost-effectiveness of changing selfmonitoring
of blood glucose frequency. Diabetes
2009;58:A505.
120. Mataveli F, Turatti L, Pimazoni Netto A. Short-term
economic benefits of self monitoring blood glucose
(SMBG) in type 2 diabetes for health maintenance
organisations (HMOs). Diabetologia 2008;51:1096.
121. Erny-Albrecht KM, Tunis SL, Minshall ME,
Valentine W, Foos V, Palmer AJ. Frequency of selfmonitoring
of blood glucose in type 2 diabetes: a
cost-effectiveness modeling study in the US setting.
Diabetes 2007;56:A308–9.
122. Weber C, Neeser K, Schneider B, Heinemann L,
Lodwig V, Scherbaum WA. Cost-effectiveness of self
measurement of blood glucose (SMBG) in function
of the testing frequency in patients with type 2
diabetes. Diabetes 2007;56:A317.
123. Weber C, Erny-Albrecht K, Neeser K. Cost
effectiveness of SMBG for the treatment of non
insulin dependent diabetes mellitus. Diabetologia
2006;49:0895.
124. Neeser K, Erny-Albrecht K, Weber C. Costeffectiveness
of self-monitoring of blood glucose
in type 2 diabetic patients not receiving insulin
[comment]. [Erratum appears in Diabetes Care
2006;29:959.] Diabetes Care 2006;29:480–1.
125. Davidson MB. Cost-effectiveness of self-monitoring
of blood glucose in type 2 diabetic patients not
receiving insulin: Response to Neeser et al. Diabetes
Care 2006;29:480–1.
126. Kempf K, Neukirchen W, Martin S, Kolb H. Selfmonitoring
of blood glucose in type 2 diabetes:
a new look at published trials. Diabetologia
2008;51:686–8.
127. Davidson MB. Counterpoint: Self-monitoring
of blood glucose in type 2 diabetic patients not
receiving insulin: a waste of money. Diabetes Care
2005;28:1531–3.
128. Joslin Diabetes Center. Blood sugar monitoring
owner’s manual. URL: www.joslin.org/ (accessed
August 2009).
129. Daly JM, Hartz AJ, Xu Y, Levy BT, James PA,
Merchant ML, et al. An assessment of attitudes,
behaviors, and outcomes of patients with type 2
diabetes. J Am Board Fam Med 2009;22:280–90.
130. Wagner J, Malchoff C, Abbott G. Invasiveness as
a barrier to self-monitoring of blood glucose in
diabetes. Diabetes Technol Ther 2005;7:612–9.
131. Weijman I, Ros WJ, Rutten GE, Schaufeli WB,
Schabracq MJ, Winnubst JA. The role of workrelated
and personal factors in diabetes selfmanagement.
Patient Educ Couns 2005;59:87–96.
132. IQWiG (Institute for Quality and Efficiency in
Health Care). Urine and blood glucose self-measurement
in diabetes mellitus type 2. December 2009. URL: www.
iqwig.de/index.559.en.html (accessed 21 October
2009).
133. Aas AM, Bergstad I, Thorsby PM, Johannesen O,
Solberg M, Birkeland KI. An intensified lifestyle
intervention programme may be superior to insulin
treatment in poorly controlled Type 2 diabetic
patients on oral hypoglycaemic agents: results of a
feasibility study. Diabet Med 2005;22:316–22.
134. Farmer AJ, Heneghan C, Barnett AH, Davidson
MB, Guerci B, O’Kane M, et al. Individual patient
data meta-analysis of trials of self-monitoring of
blood glucose in non-insulin treated type 2 diabetes:
Protocol for a systematic review. Prim Care Diabetes
2009;3:117–21.
135. Malanda UL, Bot SDM, Kostense PJ, Snoek FJ,
Dekker JM, Nijpels G. Effects of self-monitoring of
glucose in non-insulin treated patients with type 2
diabetes: design of the IN CONTROL-trial. BMC
Fam Pract 2009;10.
136. Heller S. Does self monitoring of blood glucose as opposed
to urinalysis provide additional benefit to newly diagnosed
individuals with Type 2 diabetes receiving structured
education? URL: http://public.ukcrn.org.uk/Search/
StudyDetail.aspx?StudyID=3773 (accessed 13
August 2009).
137. Deutsche Diabetes Gesellschaft. Blood Glucose Self
Monitoring and HbA1c Effects on Glucose Control. May
2008. URL: http://clinicaltrials.gov/ct2/show/NCT0
0688363?term=NCT00688363&rank=1 (accessed
13 August 2009)
138. Hoffmann-La Roche. Intensive Self-Monitoring Blood
Glucose Management Added Value in Non-Insulin
Treated Type 2 Diabetes Mellitus Patients. January 2009.
URL: www.clinicaltrials.gov/ct2/show/NCT00643
474?term=NCT00643474&rank=1 (accessed 13
August 2009).
139. Medical Research Foundation, Langerhans
Foundation. Effect of Self-Monitoring of Blood Glucose
in Patients With Type 2 Diabetes Mellitus Not Using
Insulin. April 2008. URL: http://clinicaltrials.gov/
show/NCT00287807 (accessed 13 August 2009).
140. International Diabetes Center, Park Nicollet
Institute, LifeScan. Impact of self-monitoring blood
glucose frequency on glycemic control in patients with
type 2 diabetes. 2009. URL: www.parknicollet.com/
diabetes/ (accessed 13 August 2009).
141. Downs SH, Black N. The feasibility of creating a
checklist for the assessment of the methodological
quality both of randomised trials and nonrandomised
studies of health care interventions.
J Epid Community Health 1998;52:377–84.
142. Franciosi M, De Berardis G, Cavaliere I, Valentini
M, Nicolucci A. The impact of blood glucose selfmonitoring
on quality of life in type 2 diabetic
patients. Diabetes 2001;50:A391.